Fulcrum Therapeutics CEO Robert Gould's 2020 pay falls 22% to $3M
Fulcrum Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
Fulcrum Therapeutics reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, three executives at Fulcrum Therapeutics received on average a compensation package of $2M, a 8% decrease compared to previous year.
Average pay of disclosed executives at Fulcrum Therapeutics
Robert J. Gould, Chief Executive Officer, received $3M in total, which decreased by 22% compared to 2019. 74% of Gould's compensation, or $2.2M, was in option awards. Gould also received $241K in bonus and $535K in salary.
Bryan Stuart, Chief Operating Officer, received a compensation package of $1.8M, which increased by 44% compared to previous year. 66% of the compensation package, or $1.2M, was in option awards.
Curtis Oltmans, General Counsel, earned $1.4M in 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2021.